<script>
</script>

<section>
  <div class="card">
    <h4>Rise of Lung Nodule Biopsy</h4>
    <ul>
      <li>Over 415,581 chest CTs were obtained from 2006 to 2012</li>
      <li>
        Lung nodule identification increased from 24% to 41% of all scans<sup
          >1</sup
        >
      </li>
      <li>There is increase need for identification of lung nodules</li>
    </ul>
    <footer class="text-sm">
      <ol>
        <li>Am J Respir Crit Care Med. 2015. PubMed:26214244</li>
      </ol>
    </footer>
  </div>
  <aside class="notes">
    <ul>
      <li>part of reason is increased general CT</li>
      <li>part of reason is increased lung cancer screen.</li>
      <li>
        USPSTF changed 2021, last change 2013 (50-80, 20 py hx, quit 15 yrs).
        55-80, 30 y
      </li>
    </ul>
  </aside>
</section>

<section>
  <div class="card">
    <h4>Standard Biopsy Techniques Are Limited</h4>
    <ul>
      <li>
        Large size of scope limits access to peripheral nodules<sup>1</sup>
      </li>

      <li>Flexible bronchoscopy has low sensitivity for malignancy</li>
      <li>34% for lesions &#60; 2 cm and 63% for &#62; 2 cm<sup>2</sup></li>
      <li>
        Electromagnetic navigation bronchoscopy (ENB) uses 3D mapped pathway to
        lung nodule
      </li>
      <li>Recent study shows ENB with higher sensitivity around 70%</li>
      <li>
        CT guided lung biopsy still have higheset sensitivity around 90%<sup
          >3</sup
        >
      </li>
    </ul>
    <footer class="text-sm">
      <ol>
        <li>
          State-of-the-Art Modalities for Peripheral Lung Nodule Biopsy. PMID:
          29433709
        </li>
        <li>NAVIGATE Study. PMID:30476574</li>
        <li>
          Establishing the Diagnosis of Lung Cancer.
          https://doi.org/10.1378/chest.12-2353
        </li>
      </ol>
    </footer>
  </div>
  <aside class="notes">
    <ul>
      <li>
        see a nodule and need to determine if CT guided or try to recategorize
        as high/low risk?
      </li>
    </ul>
  </aside>
</section>

<section>
  <div class="card">
    <h4>Ion Robotic System</h4>
    <ul>
      <li>
        Shape-sensing robotic assisted bronchoscope is a new tool for lung
        biopsy
      </li>
      <li>
        The Ionâ„¢ Endoluminal System received its FDA approval in February 2019
      </li>
      <li>
        First published study of human use was in July 2019<sup>1</sup>
      </li>
    </ul>
    <footer>
      <ol>
        <li>First Human Use. PMID: 31352444</li>
      </ol>
    </footer>
  </div>
  <aside class="notes">
    <ul>
      <li>a</li>
    </ul>
  </aside>
</section>

<section>
  <div class="r-stretch flex items-center justify-center">
    <img
      src="assets/nodules.png"
      alt=""
      class="border border-black border-solid"
    />
  </div>
  <div class="text-base text-right mt-4">
    Vachani A, Zheng C, Amy Liu IL, Huang BZ, Osuji TA, Gould MK. The
    Probability of Lung Cancer in Patients With Incidentally Detected Pulmonary
    Nodules: Clinical Characteristics and Accuracy of Prediction Models. Chest.
    2022;161(2):562-571. doi:10.1016/j.chest.2021.07.2168
  </div>
</section>
